Exagen Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 12.772 million compared to USD 8.948 million a year ago. Operating loss was USD 5.742 million compared to USD 3.417 million a year ago. Net loss was USD 6.410 million compared to USD 3.363 million a year ago. Basic loss per share from continuing operations was USD 0.38 compared to USD 0.27 a year ago. For the half year, sales was USD 23.359 million compared to USD 18.532 million a year ago. Operating loss was USD 11.309 million compared to USD 8.638 million a year ago. Net loss was USD 12.619 million compared to USD 8.926 million a year ago. Basic loss per share from continuing operations was USD 0.84 compared to USD 0.71 a year ago.